Wei-Wu He
CIK 1542073 · Chairman and CEO · last filed 2022-06-17
Wei-Wu He is a Chairman and CEO who has filed 36 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing shows the insider bought $272.5K of CASI on Jun 17, 2022. Across all open-market trades the lifetime net is +$33.6M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
36
$33.62M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CASI Pharmaceuticals, Inc. (CASI) Delisted | Chairman and CEO | 894,553 | $0.28 | $250.5K | $33.62M | 33 | 2022-06-17 |
| CASI Pharmaceuticals, Inc. (ENMD) Delisted | Director | 465,770 | — | — | $0 | 3 | 2013-05-31 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-17 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +88,154 | $272.5K | EDGAR |
| 2021-11-19 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +400,000 | $394.0K | EDGAR |
| 2021-08-20 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +480,000 | $613.8K | EDGAR |
| 2021-06-16 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-30 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +3,000,000 | $6.15M | EDGAR |
| 2020-12-23 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Gift (G) | −380,000 | $0 | EDGAR |
| 2020-11-24 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +227,471 | $488.2K | EDGAR |
| 2020-07-24 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +4,152,426 | $7.89M | EDGAR |
| 2020-05-21 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +86,265 | $194.3K | EDGAR |
| 2020-05-19 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Buy (P) | +438,932 | $866.6K | EDGAR |